Jessica Chu
About Jessica Chu
Jessica Chu is a Scientist II currently working at Amunix Pharmaceuticals in South San Francisco, California. She has extensive experience in research and has held various positions at notable companies including AbbVie, Verily Life Sciences, and Seer.
Current Role at Amunix Pharmaceuticals
Jessica Chu serves as Scientist II at Amunix Pharmaceuticals, where she has been employed since 2022. Her role involves conducting scientific research and contributing to the development of innovative therapies. Amunix Pharmaceuticals is located in South San Francisco, California, where Jessica applies her expertise in a collaborative environment.
Previous Experience at AbbVie
Jessica Chu worked at AbbVie as Associate Scientist II from 2016 to 2018. During her tenure in South San Francisco, California, she contributed to various research projects, enhancing her skills in the pharmaceutical industry. This position provided her with valuable experience in drug development processes.
Experience at Verily Life Sciences
From 2018 to 2020, Jessica was employed as a Research Associate at Verily Life Sciences in South San Francisco, California. In this role, she engaged in research initiatives aimed at advancing healthcare solutions. Her work involved collaboration with multidisciplinary teams to drive scientific advancements.
Educational Background at The University of Texas at Austin
Jessica Chu earned her Bachelor of Science (BS) degree from The University of Texas at Austin in 2008. This educational foundation equipped her with essential knowledge and skills in the scientific field, laying the groundwork for her subsequent career in research and development.
Career Progression and Roles
Jessica has held various positions throughout her career, including roles at Stemcentrx, Inc., Harvest Technical Services, Inc. - Genentech, Inc., and Seer. Her experience spans multiple functions, including research associate roles and lab management. This diverse background has contributed to her expertise in scientific research and development.